Beta2 Glycoprotein and IgG At

The Beta2 Glycoprotein and IgG At test, offered at IntroLab Belgrade, is a targeted diagnostic tool used to detect antiphospholipid syndrome (APS) and other autoimmune disorders. This test can offer important insights into your health, particularly if you have symptoms suggesting a higher risk of thrombosis or a history of miscarriages.

What are Beta-2 Glycoprotein antibodies?

Beta-2 glycoprotein is a blood protein that plays a key role in coagulation. Antibodies against Beta-2 glycoprotein are produced by the immune system in response to this protein. Normally, the body doesn’t produce antibodies against its own proteins, but this can occur in certain autoimmune disorders.

Why is the Beta2 Glycoprotein and IgG At test needed, and who should get it?

The Beta2 Glycoprotein and IgG At test is typically performed for individuals with symptoms or a history of blood clots, or for women who have had recurrent miscarriages. It is also beneficial for those diagnosed with lupus or other autoimmune conditions.

How are the results interpreted?

The interpretation of the results depends on the clinical situation. A positive antibody result may indicate APS, but it is not a definitive diagnosis. Further testing may be necessary. Occasionally, a positive result can be found in individuals without symptoms or a history of the condition.

Test subtypes

Testing for Beta2 Glycoprotein antibodies involves several types of tests, including Beta2 Glycoprotein IgG At, as well as other variants like Beta2 Glycoprotein IgM At and Beta2 Glycoprotein IgA At.

The different antibody classes—IgG, IgM, and IgA—represent various types of immune responses to specific antigens, in this case, Beta-2 glycoprotein.

• IgG antibodies are the most common in the blood and tissues and are essential for long-term immunity against infections. Elevated levels of Beta-2 glycoprotein IgG antibodies are often linked to antiphospholipid syndrome (APS).
• IgM antibodies are the first to respond following antigen exposure. Although less frequently seen, high levels of Beta-2 glycoprotein IgM antibodies can also be indicative of APS.
• IgA antibodies are predominantly found in mucous membranes, providing localized immune defense. Though less common, Beta-2 glycoprotein IgA antibodies may be detected in some patients with APS.

The primary distinction between these tests lies in the specific type of antibodies they measure. Each antibody class reflects different aspects of the immune response and the conditions under which they are produced. Therefore, combining these tests provides a more complete understanding of the patient’s immune status, supporting more accurate diagnosis.